NCT04093947

Brief Summary

The study aims to investigate the characteristics of subjects with hypertension at onset among a cohort of apparently healthy subjects, with overweight or obesity (BMI ≥ 25 Kg / m2), and free of any drug treatment at the baseline. The evaluation includes anthropometric (weight, height, BMI, waist circumference), haematochemical (hormones, metabolic and routine) parameters and the screening for hypertension with ABPM. The diagnosis of hypertension is made in accordance with the 2017 guidelines of the American College of Cardiology / American Heart Association ACC / AHA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2019

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 18, 2019

Completed
13 days until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

September 18, 2019

Status Verified

September 1, 2019

Enrollment Period

1 year

First QC Date

August 27, 2019

Last Update Submit

September 17, 2019

Conditions

Outcome Measures

Primary Outcomes (12)

  • Insulin

    Insulin (mIU/L) concentration in serum

    At baseline

  • Potassium

    Potassium (mmol/L) concentration in serum

    At baseline

  • Sodium

    Sodium (mEq/L) concentration in serum

    At baseline

  • eGFR (estimated glomerular filtration rate)

    eGFR (ml/min/1.73 mq)

    At baseline

  • Creatinin

    Creatinin (mg/dl) concentration in serum

    At baseline

  • Uric acid

    Uric acid (mg/dL) concentration in serum

    At baseline

  • Total cholesterol

    Total cholesterol (mg/dL) concentrations in serum

    At baseline

  • Thyroid hormones (FT3, FT4)

    FT3 (pg/mL), FT4 (pg/mL) concentration in serum

    At baseline

  • HDL cholesterol

    HDL cholesterol (mg/dL) concentrations in serum

    At baseline

  • LDL cholesterol

    LDL cholesterol (mg/dL) concentrations in serum

    At baseline

  • Triglycerides

    Triglycerides (mg/dL) concentrations in serum

    At baseline

  • TSH

    TSH (mU/L) concentration in serum

    At baseline

Secondary Outcomes (3)

  • BMI

    At baseline

  • Height

    At baseline

  • Weight

    At baseline

Interventions

Observational and prospective study

Eligibility Criteria

Age35 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients who came to the Outpatient Clinic of Nutrition at the National Institute of Gastroenterology "S. de Bellis," Research Hospital, Castellana Grotte, Italy.

You may qualify if:

  • Overweight or obesity (BMI\> 25 Kg/m2)

You may not qualify if:

  • Any kind of drug
  • Hypertension
  • Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
  • Chronic inflammatory diseases
  • Renal failure
  • Liver failure
  • Angina pectoris
  • Myocardial infarction and heart failure
  • Genetic heart diseases
  • Thrombocytopenias

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Gastroenterology IRCCS S. de Bellis

Castellana Grotte, Bari, 70013, Italy

Location

MeSH Terms

Conditions

HypertensionObesity

Interventions

Observation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 27, 2019

First Posted

September 18, 2019

Study Start

October 1, 2019

Primary Completion

October 1, 2020

Study Completion

October 1, 2020

Last Updated

September 18, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations